No Compromises: Engineered RNA Polymerases For High Quality, Low-Cost mRNA Manufacturing

In this featured presentation from the 13th International mRNA Health Conference, Helge Zieler, PhD, CTO of Primrose Bio, explores the next generation of mRNA manufacturing. Dr. Zieler details how engineered RNA polymerases enable "no compromise" production, delivering high-quality mRNA while significantly reducing manufacturing costs.

Discover the performance of Primrose Bio’s latest enzymes, designed for superior capping efficiency, high integrity, and ultra-low double-stranded RNA levels, even for challenging self-amplifying RNA templates. Learn how these innovations minimize the need for expensive inputs and reduce abortive transcripts to streamline the development of advanced vaccines and therapeutics.

Access the presentation below to learn how Primrose Bio is optimizing the building blocks of next-generation therapeutics.